Unlocking RNA Insights: Leveraging nanoString nCounter for Enhanced Sensing and Quantification

rna_adobestock_643134039

Explore how NanoString technology is advancing digital gene expression analysis for biomarker discovery and clinical research.

This webinar provides an overview of NanoString technology and its unique approach to enzyme-free digital gene expression analysis. Learn how NanoString compares with qPCR and RNA sequencing, and discover key considerations for implementing this platform to support robust biomarker studies and translational research.

In this webinar, you'll learn:

  • How NanoString technology enables accurate, quantitative digital gene expression analysis
  • The advantages and limitations of NanoString compared with qPCR and RNA sequencing
  • Key considerations for implementing and validating NanoString workflows in the laborator
  • How NanoString supports biomarker discovery and clinical research through reliable gene expression profiling

As gene expression technologies continue to evolve, selecting the right analytical platform is essential for generating meaningful biological insights. Discover how NanoString technology is helping researchers overcome analytical challenges while supporting biomarker discovery and advancing precision medicine.

Complete the form below to access this webinar.

Unlocking RNA Insights: Leveraging nanoString nCounter for Enhanced Sensing and Quantification

To learn more about how Eurofins processes and protects your personal data and your rights, please read our Privacy Notice.